Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery

International Journal of Pharmaceutics

Volumn 413, Issue 1-2, 2011, Pages 229-236

  Mahmoud, Azza A ^a   El Feky, Gina S ^a   Kamel, Rabab ^a   Awad, Ghada E A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chitosan; Mucoadhesion; Nanoparticles; Ocular; Sulfobutylether cyclodextrin; Zeta potential

Indexed keywords

BETA CYCLODEXTRIN; CHITOSAN; ECONAZOLE; NANOPARTICLE;

ALBINISM; ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SOLUTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; ZETA POTENTIAL;

ADHESIVES; ADMINISTRATION, OPHTHALMIC; ADMINISTRATION, TOPICAL; ANIMALS; ANIONS; ANTIFUNGAL AGENTS; BETA-CYCLODEXTRINS; CHITOSAN; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ECONAZOLE; EXCIPIENTS; MALE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYMERS; RABBITS;

EID: 79958014984     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.031     Document Type: Article

References (25)

1. F.L. Aachmann, D.E. Otzen, K.L. Larsen, and R. Wimmer Structural background of cyclodextrin-protein interactions Protein Eng. 16 2003 905 912 (Pubitemid 38281740)
2. Y. Aktas, K. Andrieux, M.J. Alonso, P. Calvo, R.N. Gursoy, P. Couvreur, and Y. Capan Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor Int. J. Pharm. 298 2005 378 383 (Pubitemid 40910746)
3. A.H. Al-Marzouqi, H.M. Elwy, I. Shehadi, and A. Adem Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques J. Pharm. Biomed. Anal. 49 2009 227 233
4. P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, and M.J. Alonso Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers J. Appl. Polym. Sci. 63 1997 125 132 (Pubitemid 127613982)
5. T. Cerchiara, B. Luppi, F. Bigucci, and V. Zecchi Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes Int. J. Pharm. 258 2003 209 215 (Pubitemid 36712884)
6. C. Colonna, B. Conti, P. Perugini, F. Pavanetto, T. Modena, R. Dorati, P. Iadarola, and I. Genta Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy Eur. J. Pharm. Biopharm. 70 2008 58 65
7. N. Csaba, M. Garcia-Fuentes, and M.J. Alonso The performance of nanocarriers for transmucosal drug delivery Expert Opin. Drug Deliv. 3 2006 463 478
8. N. Csaba, M. Koping-Hoggard, and M.J. Alonso Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery Int. J. Pharm. 382 2009 205 214
9. F. Cui, F. Qian, and C. Yin Preparation and characterization of mucoadhesive polymer-coated nanoparticles Int. J. Pharm. 316 2006 154 161 (Pubitemid 43765702)
10. A.M. De Campos, A. Sanchez, and M.J. Alonso Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A Int. J. Pharm. 224 2001 159 168 (Pubitemid 32706495)
11. M. de la Fuente, M. Ravina, P. Paolicelli, A. Sanchez, B. Seijo, and M.J. Alonso Chitosan-based nanostructures: a delivery platform for ocular therapeutics Adv. Drug. Deliv. Rev. 62 2010 100 117
12. Y. Kawashima, H. Yamamoto, H. Takeuchi, and Y. Kuno Mucoadhesive dl-lactide/glycolide copolymer nanoparticles coated with chitosan to improve oral delivery of elcatonin Pharm. Dev. Technol. 5 2000 77 85 (Pubitemid 30069202)
13. O. Kayser, A. Lemke, and N. Hernandez-Trejo The impact of nanobiotechnology on the development of new drug delivery systems Curr. Pharm. Biotechnol. 6 2005 3 5 (Pubitemid 40246748)
14. A.H. Krauland, and M.J. Alonso Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system Int. J. Pharm. 340 2007 134 142 (Pubitemid 47043346)
15. S.K. Motwani, S. Chopra, S. Talegaonkar, K. Kohli, F.J. Ahmad, and R.K. Khar Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation Eur. J. Pharm. Biopharm. 68 2008 513 525 (Pubitemid 351318222)
16. F.A. Oyarzun-Ampuero, J. Brea, M.I. Loza, D. Torres, and M.J. Alonso Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma Int. J. Pharm. 2009
17. W. Paul, and C.P. Sharma Chitosan, a drug carrier for the 21st century: a review STP Pharma Sci. 10 2000 5 22 (Pubitemid 30126781)
18. J.E.F. Reynolds Martindale, The Extra Pharmacopoeia 31st ed. 1996 Royal Pharm. Soc., Pharmaceutical Press London
19. R.M. Schiffelers, M.C. Woodle, and P. Scaria Pharmaceutical prospects for RNA interference Pharm. Res. 21 2004 1 7 (Pubitemid 38122285)
20. W. Tiyaboonchai, and N. Limpeanchob Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles Int. J. Pharm. 329 2007 142 149 (Pubitemid 44937518)
21. U.S. Department of Health and Human Services Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms 1997 Food and Drug Administration Center for Drug Evaluation and Research (CDER)
22. I.M. van der Lubben, J.C. Verhoef, G. Borchard, and H.E. Junginger Chitosan for mucosal vaccination Adv. Drug Deliv. Rev. 52 2001 139 144 (Pubitemid 33079169)
23. G.W. Vandenberg, C. Drolet, S.L. Scott, and J. de la Noue Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation J. Control. Release 77 2001 297 307 (Pubitemid 33145481)
24. Y. Xu, and Y. Du Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles Int. J. Pharm. 250 2003 215 226 (Pubitemid 35447951)
25. V. Zia, R.A. Rajewski, and V.J. Stella Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD Pharm. Res. 18 2001 667 673 (Pubitemid 32595797)